COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
Study Information
Study Attribute Value
CEBS Accession Number: 002-01586-0002-0000-4
Chemical Name: Acetaminophen (4-hydroxyacetanilide)
CASRN: 103-90-2
NTP Study Type: Genetic Toxicology - Mammalian Cell Cytogenetics
NTP Study ID: 034886_CA
Study Result: Positive

Study Result: Positive
Activation Trial Trial Call
No Activation  Positive 
Induced Rat Liver S9  1_S9  Weakly Positive* 
Induced Rat Liver S9  2_S9  Weakly Positive 

Trial #:1   Activation: No Activation    Date: 11/04/1986    Harvest Time: 20 hour(s)   Trial Call: Positive   
  Dose
µg/mL
Total
Cells Examined
Total Aberrations Complex Aberrations Simple Aberrations Other Abs
No. of
Abs
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
Vehicle Control: Negative (Not Specified)
0         
200 6 0.030 2.5 3 0.015 1.5 2 0.010 0.5 1 0.005 0.5
Dimethyl Sulfoxide
0         
200 6 0.030 3.0 1 0.005 0.5 1 0.005 0.5 4 0.020 2.0
Test Chemical: Acetaminophen (4-hydroxyacetanilide)
1257         
60 60 1.000 43.3 17 0.283 18.3 22 0.367 25.0 21 0.350 5.0
2513         
58 27 0.466 27.6 7 0.121 8.6 15 0.259 12.1 5 0.086 8.6
3750         
75 50 0.667 42.7 10 0.133 8.0 25 0.333 20.0 15 0.200 20.0
5000         
200 30 0.150 8.5 3 0.015 1.5 10 0.050 3.0 17 0.085 4.0
Positive Control: Mitomycin-C
 0.05      
200 38 0.190 16.0 22 0.110 9.5 16 0.080 7.0 0 0.000 0.0
Mitomycin-C
 0.08      
25 20 0.800 56.0 10 0.400 32.0 10 0.400 28.0 0 0.000 0.0
Trend: 2.307 0.071 1.238  
Probability: 0.011 0.472 0.108  


Trial #:1_S9   Activation: Induced Rat Liver S9    Date: 11/04/1986    Harvest Time: 12 hour(s)   Trial Call: Weakly Positive*   
  Dose
µg/mL
Total
Cells Examined
Total Aberrations Complex Aberrations Simple Aberrations Other Abs
No. of
Abs
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
Vehicle Control: Negative (Not Specified)
0         
200 3 0.015 1.5 3 0.015 1.5 0 0.000 0.0 0 0.000 0.0
Dimethyl Sulfoxide
0         
200 5 0.025 2.5 1 0.005 0.5 4 0.020 2.0 0 0.000 0.0
Test Chemical: Acetaminophen (4-hydroxyacetanilide)
2513         
200 6 0.030 3.0 4 0.020 2.0 2 0.010 1.0 0 0.000 0.0
3750         
200 13 0.065 4.5 9 0.045 4.0 3 0.015 1.0 1 0.005 0.5
5000         
200 31 0.155 11.0 13 0.065 5.5 17 0.085 7.0 1 0.005 0.5
Positive Control: Cyclophosphamide
7.5       
200 15 0.075 7.5 5 0.025 2.5 10 0.050 5.0 0 0.000 0.0
Cyclophosphamide
37.5       
25 10 0.400 24.0 3 0.120 12.0 7 0.280 16.0 0 0.000 0.0
Trend: 3.726 3.155 2.740  
Probability: 0.000 0.001 0.003  


Trial #:2_S9   Activation: Induced Rat Liver S9    Date: 01/16/1987    Harvest Time: 12 hour(s)   Trial Call: Weakly Positive   
  Dose
µg/mL
Total
Cells Examined
Total Aberrations Complex Aberrations Simple Aberrations Other Abs
No. of
Abs
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
No. of
Abs.
Abs
Per
Cell
% Cells
With
Abs
Vehicle Control: Negative (Not Specified)
0         
100 1 0.010 1.0 1 0.010 1.0 0 0.000 0.0 0 0.000 0.0
Dimethyl Sulfoxide
0         
100 2 0.020 2.0 0 0.000 0.0 2 0.020 2.0 0 0.000 0.0
Test Chemical: Acetaminophen (4-hydroxyacetanilide)
3800         
100 10 0.100 5.0 6 0.060 4.0 4 0.040 3.0 0 0.000 0.0
4400         
100 10 0.100 8.0 3 0.030 3.0 7 0.070 5.0 0 0.000 0.0
5000         
100 15 0.150 12.0 6 0.060 5.0 9 0.090 7.0 0 0.000 0.0
Positive Control: Cyclophosphamide
7.5       
100 17 0.170 17.0 3 0.030 3.0 14 0.140 14.0 0 0.000 0.0
Cyclophosphamide
37.5       
25 20 0.800 56.0 12 0.480 44.0 8 0.320 28.0 0 0.000 0.0
Trend: 2.935 1.822 1.882  
Probability: 0.002 0.034 0.030